Research and Markets (http://www.researchandmarkets.com/research/68hptn/nicotine) has announced the addition of the "Nicotine Addiction-Pipeline Insights, 2015" subscription to their offering.
This Nicotine Addiction Pipeline Insights report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Nicotine Addiction.
This report provides information on the therapeutic development based on the Nicotine Addiction dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.
The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Key Topics Covered:
- Nicotine Addiction Overview
- Nicotine Addiction Pipeline Therapeutics
- Nicotine Addiction Therapeutics under Development by Companies
- Nicotine Addiction Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Nicotine Addiction Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Nicotine Addiction Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Nicotine Addiction Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Nicotine Addiction - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Nicotine Addiction - Discontinued Products
- Nicotine Addiction - Dormant Products
- Companies Involved in Therapeutics Development for Nicotine Addiction
- Appendix
For more information visit http://www.researchandmarkets.com/research/68hptn/nicotine